Healthcare provider profile · identity verified

Marc Bernard Gladden, D.O.

Internal Medicine · BEAVER DAM, WI · NPI 1073802161

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	537	152
Levothyroxine Sodium	Levothyroxine Sodium	345	93
Lisinopril	Lisinopril	339	100
Omeprazole	Omeprazole	289	82
Metoprolol Succinate	Metoprolol Succinate	247	62
Tamsulosin Hcl	Tamsulosin Hcl	241	68
Amlodipine Besylate	Amlodipine Besylate	224	74
Losartan Potassium	Losartan Potassium	210	58
Furosemide	Furosemide	196	63
Simvastatin	Simvastatin	166	41
Metformin Hcl	Metformin Hcl	150	41
Potassium Chloride	Potassium Chloride	141	38
Carvedilol	Carvedilol	135	25
Pantoprazole Sodium	Pantoprazole Sodium	131	38
Tramadol Hcl	Tramadol Hcl	120	39
Eliquis	Apixaban	119	27
Famotidine	Famotidine	118	33
Gabapentin	Gabapentin	118	41
Rosuvastatin Calcium	Rosuvastatin Calcium	115	35
Metoprolol Tartrate	Metoprolol Tartrate	106	27
Sertraline Hcl	Sertraline Hcl	106	30
Albuterol Sulfate Hfa	Albuterol Sulfate	105	43
Hydrochlorothiazide	Hydrochlorothiazide	100	28
Finasteride	Finasteride	90	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	84	32
Clopidogrel	Clopidogrel Bisulfate	76	20
Duloxetine Hcl	Duloxetine Hcl	72	18
Metformin Hcl Er	Metformin Hcl	69	23
Allopurinol	Allopurinol	66	19
Trazodone Hcl	Trazodone Hcl	66	23
Warfarin Sodium	Warfarin Sodium	66	14
Pravastatin Sodium	Pravastatin Sodium	65	20
Tizanidine Hcl	Tizanidine Hcl	64	15
Fluticasone Propionate	Fluticasone Propionate	63	27
Jardiance	Empagliflozin	62	15
Alendronate Sodium	Alendronate Sodium	61	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	59	15
Labetalol Hcl	Labetalol Hcl	58	16
Pregabalin	Pregabalin	58	17
Lorazepam	Lorazepam	51	suppressed
Chlorthalidone	Chlorthalidone	49	19
Xarelto	Rivaroxaban	49	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	45	suppressed
Glipizide Er	Glipizide	44	13
Montelukast Sodium	Montelukast Sodium	43	11
Memantine Hcl	Memantine Hcl	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Bupropion Hcl Sr	Bupropion Hcl	38	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	18
Escitalopram Oxalate	Escitalopram Oxalate	38	11
Irbesartan	Irbesartan	37	11
Donepezil Hcl	Donepezil Hcl	35	13
Valsartan	Valsartan	35	suppressed
Verapamil Er	Verapamil Hcl	35	suppressed
Glimepiride	Glimepiride	34	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	33	suppressed
Ezetimibe	Ezetimibe	33	12
Fenofibrate	Fenofibrate	33	suppressed
Nitroglycerin	Nitroglycerin	32	22
Terazosin Hcl	Terazosin Hcl	32	suppressed
Alprazolam	Alprazolam	31	suppressed
Clonazepam	Clonazepam	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Sucralfate	Sucralfate	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Glipizide	Glipizide	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Spironolactone	Spironolactone	29	11
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	15
Ozempic	Semaglutide	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Bumetanide	Bumetanide	26	suppressed
Celecoxib	Celecoxib	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Baclofen	Baclofen	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	15
Topiramate	Topiramate	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	21	suppressed
Naproxen	Naproxen	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Nystatin	Nystatin	19	11
Diazepam	Diazepam	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Temazepam	Temazepam	17	suppressed
Atenolol	Atenolol	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Cephalexin	Cephalexin	16	15
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Prednisone	Prednisone	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	11
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Metolazone	Metolazone	14	suppressed
Fentanyl	Fentanyl	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Lithium Carbonate Er	Lithium Carbonate	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Testosterone	Testosterone	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Vraylar	Cariprazine Hcl	12	suppressed
Azithromycin	Azithromycin	11	11
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error